BioLife Solutions: director Timothy L. Moore sold 44,943 shares

What happened

• The Form 4 reports that Timothy L. Moore, a director, disposed of 44,943 shares of BioLife Solutions common stock on Oct 06, 2026. The transaction line lists the price as N/A.
• Footnote F1 states the disposition occurred in connection with the Oct 06, 2026 merger: each share was converted into $11.25 in cash and 0.1442 shares of Repligen common stock. That equals $505,608.75 in cash and 6,480.7806 Repligen shares for 44,943 BioLife shares.

Key details

• Transaction date and price: Oct 06, 2026; price shown as N/A in the transaction table; conversion terms $11.25 cash and 0.1442 Repligen shares per BioLife share (per footnote F1).
• Shares owned after the transaction: not reported in the Form 4 provided.
• Filing date and accession: filed Oct 08, 2026 (Accession 0001193125-26-418316).
• Footnote F1: disposition was pursuant to the merger of Bravo Merger Sub I, Inc. with BioLife under the Merger Agreement dated Jul 21, 2026.

Why it may matter

• The filing shows this was a disposition to the issuer under the merger terms (conversion into cash and Repligen stock), not a market sale.
• A filing does not show why the insider traded or why the company acted.